Dehydroepiandrosterone stimulates neurogenesis in mouse embryonal carcinoma cell- and human embryonic stem cell-derived neural progenitors and induces dopaminergic neurons

Stem Cells and Development

Volumn 19, Issue 6, 2010, Pages 809-818

  Azizi, Hossein ^a   Mehrjardi, Narges Zare ^a   Shahbazi, Ebrahim ^a   Hemmesi, Katayoun ^a   Bahmani, Mirza Khalil ^b   Baharvand, Hossein ^a  

^a UNIVERSITY OF SCIENCE AND CULTURE   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; NESTIN; NUCLEAR RECEPTOR RELATED FACTOR 1; PRASTERONE; RETINOIC ACID; TRANSCRIPTION FACTOR MASH1; TRANSCRIPTION FACTOR PAX6; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYONAL CARCINOMA STEM CELL; EMBRYONIC STEM CELL; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MOUSE; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

ANIMALS; APOPTOSIS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DEHYDROEPIANDROSTERONE; DOPAMINE; EMBRYONAL CARCINOMA STEM CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MICE; NEUROGENESIS; NEURONS; TRETINOIN;

EID: 77954202194     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.0261     Document Type: Article

References (43)

1. Baulieu EE. (1997). Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog Horm Res 52:1-32.
2. Weill-Engerer S, JP David, V Sazdovitch, P Liere, B Eychenne, A Pianos, M Schumacher, A Delacourte, EE Baulieu and Y Akwa. (2002). Neurosteroid quantifi cation in human brain regions: comparison between Alzheimer's and nondemented patients. J Clin Endocrinol Metab 87:5138-5143.
3. Frank C and S Sagratella. (2000). Neuroprotective effects of allopregnenolone on hippocampal irreversible neurotoxicity in vitro. Prog Neuropsychopharmacol Biol Psychiatry 24:1117-1126.
4. Lockhart EM, DS Warner, RD Pearlstein, DH Penning, S Mehrabani and RM Boustany. (2002). Allopregnanolone attenuates N-methyl-d-aspartate-induced excitotoxicity and apoptosis in the human NT2 cell line in culture. Neurosci Lett 328:33-36.
5. Djebaili M, Q Guo, EH Pettus, SW Hoffman and DG Stein. (2005). The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional defi cits after traumatic brain injury in rats. J Neurotrauma 22:106-118.
6. Djebaili M, SW Hoffman and DG Stein. (2004). Allopregnanolone and progesterone decrease cell death and cognitive defi cits after a contusion of the rat pre-frontal cortex. Neuroscience 123:349-359.
7. Suzuki M, LS Wright, P Marwah, HA Lardy and CN Svendsen. (2004). Mitotic and neurogenic effects of dehydroepiandrosterone (DHEA) on human neural stem cell cultures derived from the fetal cortex. Proc Natl Acad Sci USA 101:3202-3207.
8. Karishma KK and J Herbert. (2002). Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur J Neurosci 16:445-453.
9. Baulieu EE. (1998). Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 23:963-987.
10. Naylor JC, CM Hulette, DC Steffens, LJ Shampine, JF Ervin, VM Payne, MW Massing, JD Kilts, JL Strauss, PS Calhoun, RP Calnaido, DG Blazer, JA Lieberman, RD Madison and CE Marx. (2008). Cerebrospinal fl uid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stage. J Clin Endocrinol Metab 93:3173-3178.
11. Compagnone NA and SH Mellon. (1998). Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development. Proc Natl Acad Sci USA 95:4678-4683.
12. Charalampopoulos I, VI Alexaki, C Tsatsanis, V Minas, E Dermitzaki, I Lasaridis, L Vardouli, C Stournaras, AN Margioris, E Castanas and A Gravanis. (2006). Neurosteroids as endogenous inhibitors of neuronal cell apoptosis in aging. Ann N Y Acad Sci 1088:139-152.
13. Murashov AK, ES Pak, WA Hendricks and LM Tatko. (2004). 17beta-Estradiol enhances neuronal differentiation of mouse embryonic stem cells. FEBS Lett 569:165-168.
14. Tomas-Camardiel M, MC Sanchez-Hidalgo, MJ Sanchez del Pino, A Navarro, A Machado and J Cano. (2002). Comparative study of the neuroprotective effect of dehydroepiandrosterone and 17beta-estradiol against 1-methyl-4-phenylpyridium toxicity on rat striatum. Neuroscience 109:569-584.
15. Corphot C, P Robel, M Axelson, J Sjall and EE Baulieu. (1981). Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc Natl Acad Sci USA 78:4704-4707.
16. Baharvand H, SK Ashtiani, A Taee, M Massumi, MR Valojerdi, PE Yazdi, SZ Moradi and A Farrokhi. (2006). Generation of new human embryonic stem cell lines with diploid and triploid karyotypes. Dev Growth Differ 48:117-128.
17. Hatami M, NZ Mehrjardi, S Kiani, K Hemmesi, H Azizi, A Shahverdi and H Baharvand. (2009). Human embryonic stem cellderived neural precursor transplants in collagen scaffolds promote recovery in injured rat spinal cord. Cytotherapy 11:618-630.
18. Livak KJ and TD Schmittgen. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
19. Martin C, M Ross, KE Chapman, R Andrew, P Bollina, JR Seckl and FK Habib. (2004). CYP7B generates a selective estrogen receptor beta agonist in human prostate. J Clin Endocrinol Metab 89:2928-2935.
20. Morissette M, S Al Sweidi, S Callier and T Di Paolo. (2008). Estrogen and SERM neuroprotection in animal models of Parkinson's disease. Mol Cell Endocrinol 290:60-69.
21. Silvagno F, V Guarnieri, A Capizzi and GP Pescarmona. (2002). Synergistic effect of retinoic acid and dehydroepiandrosterone on differentiation of human neuroblastoma cells. FEBS Lett 532:153-158.
22. Shiri EH, NZ Mehrjardi, M Tavallaei, SK Ashtiani and H Baharvand. (2009). Neurogenic and mitotic effects of dehydroepiandrosterone on neuronal-competent marrow mesenchymal stem cells. Int J Dev Biol 53:579-584.
23. Webb SJ, TE Geoghegan, RA Prough and KK Michael Miller. (2006). The biological actions of dehydroepiandrosterone involves multiple receptors. Drug Metab Rev 38:89-116.
24. Labrie F. (2004). Adrenal androgens and intracrinology. Semin Reprod Med 22:299-309.
25. Chalbot S and R Morfi n. (2006). Dehydroepiandrosterone metabolites and their interactions in humans. Drug Metabol Drug Interact 22:1-23.
26. Belelli D and JJ Lambert. (2005). Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat Rev Neurosci 6:565-575.
27. Xilouri M, N Avlonitis, T Calogeropoulou and P Papazafi ri. (2007). Neuroprotective effects of steroid analogues on P19-N neurons. Neurochem Int 50:660-670.
28. Xilouri M and P Papazafi ri. (2006). Anti-apoptotic effects of allopregnanolone on P19 neurons. Eur J Neurosci 23:43-54.
29. Cheng ZX, DM Lan, PY Wu, YH Zhu, Y Dong, L Ma and P Zheng. (2008). Neurosteroid dehydroepiandrosterone sulphate inhibits persistent sodium currents in rat medial prefrontal cortex via activation of sigma-1 receptors. Exp Neurol 210:128-136.
30. Laurine E, D Lafi tte, C Gr?oire, E Sean, E Loret, S Douillard, B Michel, C Briand and JM Verdier. (2003). Specifi c binding of dehydroepiandrosterone to the N terminus of the microtubuleassociated protein MAP2. J Biol Chem 278:29979-29986.
31. Kohalmy K, V Tami, L Kori, E Siviy, JM Pascussi, P Porrogi, D Rozman, RA Prough, UA Meyer and K Monostory. (2007). Dehydroepiandrosterone induces human CYP2B6 through the constitutive androstane receptor. Drug Metab Dispos 35:1495-1501.
32. Tamasi V, KK Miller, SL Ripp, E Vila, TE Geoghagen and RA Prough. (2008). Modulation of receptor phosphorylation contributes to activation of peroxisome proliferator activated receptor alpha by dehydroepiandrosterone and other peroxisome proliferators. Mol Pharmacol 73:968-976.
33. Brinvall K, L Korhonen and D Lindholm. (2002). Estrogenreceptor-dependent regulation of neural stem cell proliferation and differentiation. Mol Cell Neurosci 21:512-520.
34. Schmitt M, K Klinga, B Schnarr, R Morfi n and D Mayer. (2001). Dehydroepiandrosterone stimulates proliferation and gene expression in MCF-7 cells after conversion to estradiol. Mol Cell Endocrinol 173:1-13.
35. Zhang L, B Li, W Ma, JL Barker, YH Chang, W Zhao and DR Rubinow. (2002). Dehydroepiandrosterone (DHEA) and its sulfated derivative (DHEAS) regulate apoptosis during neurogenesis by triggering the Akt signaling pathway in opposing ways. Brain Res Mol Brain Res 98:58-66.
36. Charalampopoulos I, C Tsatsanis, E Dermitzaki, VI Alexaki, E Castanas, AN Margioris and A Gravanis. (2004). Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins. Proc Natl Acad Sci USA 101:8209-8214.
37. Xilouri M and P Papazafi ri. (2008). Induction of Akt by endogenous neurosteroids and calcium sequestration in P19 derived neurons. Neurotox Res 13:209-219.
38. Cardounel A, W Regelson and M Kalimi. (1999). Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action. Proc Soc Exp Biol Med 222:145-149.
39. Ye ZC and H Sontheimer. (1998). Astrocytes protect neurons from neurotoxic injury by serum glutamate. Glia 22:237-248.
40. Kaasik A, D Safi ulina, A Kalda and A Zharkovsky. (2003). Dehydroepiandrosterone with other neurosteroids preserve neuronal mitochondria from calcium overload. J Steroid Biochem Mol Biol 87:97-103.
41. Diz NF, NE Diz-Martéz, I Camacho-Arroyo and I Velasco. (2009). Estradiol promotes proliferation of dopaminergic precursors resulting in a higher proportion of dopamine neurons derived from mouse embryonic stem cells. Int J Dev Neurosci 27:493-500.
42. Charalampopoulos I, E Dermitzaki, L Vardouli, C Tsatsanis, C Stournaras, AN Margioris and A Gravanis. (2005). Dehydroepiandrosterone sulfate and allopregnanolone directly stimulate catecholamine production via induction of tyrosine hydroxylase and secretion by affecting actin polymerization. Endocrinology 146:3309-3318.
43. D'Astous M, M Morissette, B Tanguay, S Callier and T Di Paolo. (2003). Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice. Synapse 47:10-14.